Publication: Efficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options.
cris.virtualsource.author-orcid | 3ffc609d-4653-413a-a80f-2bf6c2b71f47 | |
cris.virtualsource.author-orcid | d8f42926-f873-4a1f-839a-49eecd87333a | |
cris.virtualsource.author-orcid | 1b65be99-ede2-4b0e-8e6d-1c720e453513 | |
datacite.rights | restricted | |
dc.contributor.author | Schmid, Jonas Andreas | |
dc.contributor.author | Festl, Yasmin | |
dc.contributor.author | Severin, Yannik | |
dc.contributor.author | Bacher, Vera Ulrike | |
dc.contributor.author | Kronig, Marie-Noëlle | |
dc.contributor.author | Snijder, Berend | |
dc.contributor.author | Pabst, Thomas Niklaus | |
dc.date.accessioned | 2024-10-25T16:55:11Z | |
dc.date.available | 2024-10-25T16:55:11Z | |
dc.date.issued | 2024-02-01 | |
dc.description.abstract | Not available. | |
dc.description.note | Antwort Meddek: In diesem Fall wird eine eigene prospektive Observationsstudie mit n=24 Patienten inkl. stat. Auswertung und graph. Darstellung im Letter inkludiert. -> Kann als Kat. A / Originalartikel inhouse gezählt werden, 24.06.2025/A. Stettler | |
dc.description.numberOfPages | 5 | |
dc.description.sponsorship | Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor | |
dc.description.sponsorship | Universitätsklinik für Medizinische Onkologie | |
dc.identifier.doi | 10.48350/184768 | |
dc.identifier.pmid | 37439341 | |
dc.identifier.publisherDOI | 10.3324/haematol.2023.283224 | |
dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/168683 | |
dc.language.iso | en | |
dc.publisher | Ferrata-Storti Foundation | |
dc.relation.ispartof | Haematologica - the hematology journal | |
dc.relation.issn | 0390-6078 | |
dc.relation.organization | DCD5A442C448E17DE0405C82790C4DE2 | |
dc.relation.organization | DCD5A442C055E17DE0405C82790C4DE2 | |
dc.subject.ddc | 600 - Technology::610 - Medicine & health | |
dc.title | Efficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options. | |
dc.type | article | |
dspace.entity.type | Publication | |
dspace.file.type | text | |
oaire.citation.endPage | 621 | |
oaire.citation.issue | 2 | |
oaire.citation.startPage | 617 | |
oaire.citation.volume | 109 | |
oairecerif.author.affiliation | Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor | |
oairecerif.author.affiliation | Universitätsklinik für Medizinische Onkologie | |
oairecerif.author.affiliation | Universitätsklinik für Medizinische Onkologie | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.date.licenseChanged | 2023-07-14 15:49:23 | |
unibe.description.ispublished | pub | |
unibe.eprints.legacyId | 184768 | |
unibe.journal.abbrevTitle | HAEMATOL-HEMATOL J | |
unibe.refereed | true | |
unibe.subtype.article | journal |
Files
Original bundle
1 - 1 of 1
- Name:
- 11155-Article_Text-81539-1-10-20230713.pdf
- Size:
- 2.33 MB
- Format:
- Adobe Portable Document Format
- File Type:
- text
- License:
- publisher
- Content:
- accepted